Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment (E-3 PTSD)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00699660
First received: June 12, 2008
Last updated: April 18, 2013
Last verified: March 2012

June 12, 2008
April 18, 2013
May 2009
September 2010   (final data collection date for primary outcome measure)
completeness and quality of PTSD interview [ Time Frame: Post-exam, same day ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00699660 on ClinicalTrials.gov Archive Site
  • PTSD diagnosis [ Time Frame: post-exam, same day ] [ Designated as safety issue: No ]
  • Patient Satisfaction [ Time Frame: post-exam, same day ] [ Designated as safety issue: No ]
  • resource utilization [ Time Frame: same day ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment
Enhancing Equitable and Effective PTSD Disability Assessment

This project evaluated the impact of semi-structured, standardized interviews on the initial PTSD C&P on the examination.

Our objective is to compare the process and outcomes of C&P exams for PTSD conducted with CAPS and WHODAS-II interviews versus the PTSD exams conducted without the CAPS and WHODAS-II interviews. This project will conduct a randomized controlled trial on 688 veterans to evaluate the effects of the CAPS/WHODAS instruments on the initial PTSD C&P examination process. Study outcomes include variation in assessing the DSM-IV components of PTSD, diagnostic accuracy, veteran perception of the exam process, VBA rater utility and resource utilization. This project will 1) demonstrate the feasibility of conducting program evaluation and intervention studies on the PTSD C&P examination process, 2) develop research tools, instruments and methods for C&P evaluation, 3) provide data on the value-added contribution of CAPS and WHODAS-II to the PTSD assessment process and examination report, and 4) inform the business case of utilizing the CAPS and WHODAS-II in the PTSD C&P process. The ultimate aim is to improve the reproducibility, consistency and validity of the PTSD examination process while maintaining a level of efficiency and cost restraint that provides veterans with an exam process that is fair, accurate and equitable across VHA.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Post-Traumatic Stress Disorder
  • Behavioral: Clinician Assessment of PTSD Symptoms (CAPS)
    CAPS/WHODAS structured clinical PTSD interview
  • Behavioral: Nonstructured Interview
    Usual PTSD clinical PTSD interview, not CAPS or SCID
  • Experimental: Arm 1
    PTSD interview using CAPS and WHODAS
    Intervention: Behavioral: Clinician Assessment of PTSD Symptoms (CAPS)
  • Active Comparator: Arm 2
    Usual PTSD interview, without CAPS or WHODAS
    Intervention: Behavioral: Nonstructured Interview

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
370
September 2011
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Veterans referred to VHA for an Initial PTSD Compensation and Pension Examination
  2. Informed consent

Exclusion Criteria:

  1. Mentally impaired, not able to give informed consent
  2. English speaking
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00699660
SDR 06-331
Yes
Department of Veterans Affairs
Department of Veterans Affairs
Not Provided
Principal Investigator: Theodore Speroff, PhD Department of Veterans Affairs
Department of Veterans Affairs
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP